ReadWriteWeb included PatientsLikeMe, a CommerceNet portfolio company, in their list of top “real world apps that have made our offline lives easier in 2008.”
“PatientsLikeMe is an online community for people with life-changing medical conditions like multiple sclerosis, post-traumatic stress disorder, or fibromyalgia. Even though the site is still relatively new, it already provides one of the largest patient communities, and also features a wide range of research tools for symptoms and treatments.
“PatientsLikeMe was founded in 2004 and defines its mission as providing a platform for sharing real world medical data. Members of the site often share data about their individual health experiences like symptoms, weight, mood swings, or drugs they have taken. Thanks to this, you can easily find others who are in the same situation as you and what treatments are working for them.”
https://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.png00amshttps://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.pngams2008-12-25 18:38:402016-12-11 03:10:58PatientsLikeMe Named a Top Real World App of 2008
In a November 23, 2008, post on the Patient Safety Blog, Ken Farbstein discusses how PatientsLikeMe, a CommerceNet portfolio company, sheds light on the effectiveness of drugs in clinical trials.
His advice: Patients interested in clinical drug trails should look into PatientsLikeMe.
https://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.png00amshttps://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.pngams2008-11-25 17:08:372016-12-11 03:12:37Thousands of Patients Won’t Take It: Online Drug Studies Using PatientsLikeMe
John Willbanks, VP of Science at Creative Commons, will be talking about the Health Commons initiative at the upcoming InnovationWell Community of Practice InterAction Meeting on October 14 – 17, 2008 in Philadelphia. Health Commons is collaboration between CommerceNet, Science Commons, and the Public Library of Science to transform drug discovery.
Abstract: Breaking Down Barriers to Collaboration–The Health Commons InitiativeImagine a virtual marketplace or ecosystem where participants share data, knowledge, materials and services to accelerate research. The components might include databases on the results of chemical assays, toxicity screens, and clinical trials; libraries of drugs and chemical compounds; repositories of biological materials (tissue samples, cell lines, molecules), computational models predicting drug efficacies or side effects, and contract services for high-throughput genomics and proteomics, combinatorial drug screening, animal testing, biostatistics, and more. The resources offered through the Commons might not necessarily be free, though many could be. However, all would be available under standard pre-negotiated terms and conditions and with standardized data formats that eliminate the debilitating delays, legal wrangling and technical incompatibilities that frustrate scientific collaboration today.
We envision a Commons where a researcher will be able to order everything needed to replicate a published experiment as easily as ordering DVDs from Amazon. A Commons where one can create a workflow to exploit replicated results on an industrial scale–searching the world’s biological repositories for relevant materials; routing them to the best labs for molecular profiling; forwarding the data to a team of bioinfomaticians for collaborative analysis of potential drug targets; and finally hiring top service providers to run drug screens against those targets; with everything–knowledge, data, and materials–moving smoothly from one provider to the next, monitored and tracked with Fed-Ex precision; where the workflow scripts themselves can become part of the Commons, for others to reuse and improve. Health Commons’ marketplace will slash the time, cost, and risk of developing treatments for diseases. Individual researchers, institutions, and companies will be able to publish information about their expertise and resources so that others in the community can readily discover and use them. Core competencies, from clinical trial design to molecular profiling, will be packaged as turnkey services and made available over the Net. The Commons will serve as the public-domain, non-profit hub, with third-parties providing value added services that facilitate information access, communication, and collaboration.
https://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.png00amshttps://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.pngams2008-09-21 22:47:402016-12-11 03:13:27Breaking Down Barriers to Collaboration–The Health Commons Initiative
Dr. Donald Kennedy, president emeritus at Stanford University, former editor-in-chief of Science, and FDA commissioner under President Carter, will chair the scientific advisory board at CollabRx.
https://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.png00amshttps://commerce.net/mindystaging/wp-content/uploads/2021/09/commercenet-logo-1.pngams2008-07-24 15:00:372016-12-11 03:15:06Dr. Donald Kennedy to Lead CollabRx Scientific Advisory Board
A new immersive web platform called Vivaty Scenes lets users create tiny virtual worlds and decorate them with content from around the Internet.
After adding Vivaty Scenes, which entered public beta Tuesday, to a Facebook or AOL Instant Messenger account, users can set up a customizable “room” where they can host chat sessions or small virtual gatherings within a web browser.
PatientsLikeMe Named a Top Real World App of 2008
CommerceNet Portfolio Companies, Health CareReadWriteWeb included PatientsLikeMe, a CommerceNet portfolio company, in their list of top “real world apps that have made our offline lives easier in 2008.”
“PatientsLikeMe is an online community for people with life-changing medical conditions like multiple sclerosis, post-traumatic stress disorder, or fibromyalgia. Even though the site is still relatively new, it already provides one of the largest patient communities, and also features a wide range of research tools for symptoms and treatments.
“PatientsLikeMe was founded in 2004 and defines its mission as providing a platform for sharing real world medical data. Members of the site often share data about their individual health experiences like symptoms, weight, mood swings, or drugs they have taken. Thanks to this, you can easily find others who are in the same situation as you and what treatments are working for them.”
PatientsLikeMe was also name to ReadWriteWeb’s “Top 100 products of 2008.”
Read full “Top 10 Real World Web Apps of 2008” article
Thousands of Patients Won’t Take It: Online Drug Studies Using PatientsLikeMe
Health CareIn a November 23, 2008, post on the Patient Safety Blog, Ken Farbstein discusses how PatientsLikeMe, a CommerceNet portfolio company, sheds light on the effectiveness of drugs in clinical trials.
His advice: Patients interested in clinical drug trails should look into PatientsLikeMe.
Read “Thousans of Patients Won’t Take It: Online Drug Studies Using PatientsLikeMe”
Breaking Down Barriers to Collaboration–The Health Commons Initiative
Health CareJohn Willbanks, VP of Science at Creative Commons, will be talking about the Health Commons initiative at the upcoming InnovationWell Community of Practice InterAction Meeting on October 14 – 17, 2008 in Philadelphia. Health Commons is collaboration between CommerceNet, Science Commons, and the Public Library of Science to transform drug discovery.
Abstract: Breaking Down Barriers to Collaboration–The Health Commons Initiative Imagine a virtual marketplace or ecosystem where participants share data, knowledge, materials and services to accelerate research. The components might include databases on the results of chemical assays, toxicity screens, and clinical trials; libraries of drugs and chemical compounds; repositories of biological materials (tissue samples, cell lines, molecules), computational models predicting drug efficacies or side effects, and contract services for high-throughput genomics and proteomics, combinatorial drug screening, animal testing, biostatistics, and more. The resources offered through the Commons might not necessarily be free, though many could be. However, all would be available under standard pre-negotiated terms and conditions and with standardized data formats that eliminate the debilitating delays, legal wrangling and technical incompatibilities that frustrate scientific collaboration today.
We envision a Commons where a researcher will be able to order everything needed to replicate a published experiment as easily as ordering DVDs from Amazon. A Commons where one can create a workflow to exploit replicated results on an industrial scale–searching the world’s biological repositories for relevant materials; routing them to the best labs for molecular profiling; forwarding the data to a team of bioinfomaticians for collaborative analysis of potential drug targets; and finally hiring top service providers to run drug screens against those targets; with everything–knowledge, data, and materials–moving smoothly from one provider to the next, monitored and tracked with Fed-Ex precision; where the workflow scripts themselves can become part of the Commons, for others to reuse and improve. Health Commons’ marketplace will slash the time, cost, and risk of developing treatments for diseases. Individual researchers, institutions, and companies will be able to publish information about their expertise and resources so that others in the community can readily discover and use them. Core competencies, from clinical trial design to molecular profiling, will be packaged as turnkey services and made available over the Net. The Commons will serve as the public-domain, non-profit hub, with third-parties providing value added services that facilitate information access, communication, and collaboration.
Dr. Donald Kennedy to Lead CollabRx Scientific Advisory Board
Health CareDr. Donald Kennedy, president emeritus at Stanford University, former editor-in-chief of Science, and FDA commissioner under President Carter, will chair the scientific advisory board at CollabRx.
Read more about Dr. Donald Kennedy
Vivaty Scenes Taps Facebook, AIM for ‘Immersive Internet’
Innovation, UncategorizedBy Earnest Cavalli
WIRED Blog Network
A new immersive web platform called Vivaty Scenes lets users create tiny virtual worlds and decorate them with content from around the Internet.
After adding Vivaty Scenes, which entered public beta Tuesday, to a Facebook or AOL Instant Messenger account, users can set up a customizable “room” where they can host chat sessions or small virtual gatherings within a web browser.
Read full article